Skip to main content
. Author manuscript; available in PMC: 2021 Jun 1.
Published in final edited form as: Eur J Pharm Biopharm. 2020 Apr 23;151:189–198. doi: 10.1016/j.ejpb.2020.04.010

Figure 3.

Figure 3.

Monitoring of nanoparticle size of LIN-LPN in serum-supplemented medium at 37 °C. Nanoparticles without drug (0%) or with linezolid (12% payload) were studied.